The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The Unregulated World of Peptides: A Legal Minefield for Providers Holt Law FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance[v3] Preprints.org FDA moves toward easing restrictions on certain peptides BioPharma Dive